American Healthcare REIT officer sells 2,000 shares

EVP, GC & Secretary Mark E. Foster’s Form 4 sale under a Rule 10b5-1 plan cut his direct holdings to 51,617 shares after 2,000 were sold at $55.39.

Rhea-AI Filing Summary

American Healthcare REIT, Inc. (AHR) officer Mark E. Foster, EVP, GC & Secretary, reported selling 2,000 shares of common stock on 2026-09-01 at $55.39 per share in an open-market or private transaction. The sale was executed under a Rule 10b5-1 trading plan adopted on 2025-12-19 and made pursuant to an exception to a lock-up agreement related to the company’s offering that closed on 2026-08-12. Following this sale, Foster directly held 51,617 shares, which includes 622 shares acquired through the company’s Employee Stock Purchase Plan.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares

Net Sell 1 txn

Insider Foster Mark E.

Role EVP, GC & Secretary

Sold 2,000 shs ($111K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3	2,000	$55.39	$111K

Holdings After Transaction: Common Stock — 51,617 shares (Direct)

Footnotes (3)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.
2. F2. The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriters of the Issuer's offering of shares of common stock that closed on August 12, 2026.
3. F3. Includes 622 shares acquired under the Issuer's Employee Stock Purchase Plan.

Key Figures

Shares sold: 2,000 shares of Common Stock Sale price per share: $55.39 per share Shares held after transaction: 51,617 shares +3 more

6 metrics

Shares sold 2,000 shares of Common Stock Sale reported for 2026-09-01

Sale price per share $55.39 per share Price for 2,000 shares sold on 2026-09-01

Shares held after transaction 51,617 shares Direct ownership after the 2,000-share sale

ESPP shares included in holdings 622 shares Portion of post-transaction holdings from Employee Stock Purchase Plan

Rule 10b5-1 plan adoption date 2025-12-19 Date Mark E. Foster adopted the trading plan used for this sale

Offering closing date referenced in lock-up 2026-08-12 Date the issuer’s offering of common stock closed, related to lock-up exception

Key Terms

Rule 10b5-1 trading plan, lock-up agreement, Employee Stock Purchase Plan

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

lock-up agreement regulatory

"pursuant to an exception to a lock-up agreement between the Reporting Person"

A lock-up agreement is a contract that prevents company insiders and early investors from selling their shares for a fixed period after a stock sale, often after an initial public offering. It matters to investors because it temporarily limits the number of shares that can hit the market, which can keep the share price steadier; when the lock-up ends, a sudden increase in available shares can create extra volatility, revealing insiders’ confidence or lack thereof.

Employee Stock Purchase Plan financial

"Includes 622 shares acquired under the Issuer's Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AHR report for Mark E. Foster on this Form 4?

Mark E. Foster reported a sale of 2,000 shares of American Healthcare REIT, Inc. common stock on 2026-09-01 at $55.39 per share in an open-market or private transaction, as disclosed in the Form 4.

How many AHR shares does Mark E. Foster hold after this transaction?

After the reported sale, Mark E. Foster directly holds 51,617 shares of American Healthcare REIT, Inc. common stock. This total includes 622 shares acquired under the company’s Employee Stock Purchase Plan.

Was the AHR insider sale by Mark E. Foster under a Rule 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mark E. Foster on 2025-12-19, as noted in the Form 4 footnotes and affirmed by the 10b5-1 checkbox.

What was the sale price per share for Mark E. Foster’s AHR transaction?

The Form 4 reports that Mark E. Foster sold 2,000 AHR shares at $55.39 per share on 2026-09-01 in a sale characterized as an open-market or private transaction.

How does the AHR Form 4 describe the lock-up agreement for this sale?

A footnote states the sale was made pursuant to an exception to a lock-up agreement between Mark E. Foster and the underwriters of American Healthcare REIT, Inc.’s offering of common stock that closed on 2026-08-12.

Does Foster’s post-transaction AHR share count include ESPP shares?

Yes. Another footnote specifies that the 51,617 shares held after the transaction include 622 shares acquired under American Healthcare REIT, Inc.’s Employee Stock Purchase Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 09:08 PM EDT Accepted by SEC EDGAR 09/01/2026 - 09:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foster Mark E.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)(2)		2,000	D	$55.39	51,617(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

2. The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriters of the Issuer's offering of shares of common stock that closed on August 12, 2026.

3. Includes 622 shares acquired under the Issuer's Employee Stock Purchase Plan.

	/s/ MARK E. FOSTER	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)